These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9056742)

  • 1. Sensitivity of combined DNA/immunophenotype flow cytometry for the detection of low levels of aneuploid lymphoblastic leukemia cells in bone marrow.
    Nowak R; Oelschlaegel U; Schuler U; Zengler H; Hofmann R; Ehninger G; Andreeff M
    Cytometry; 1997 Feb; 30(1):47-53. PubMed ID: 9056742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of aneuploid cells in acute lymphoblastic leukemia with flow cytometry before and after therapy.
    Nowak R; Oelschlägel U; Hofmann R; Zengler H; Huhn R
    Leuk Res; 1994 Dec; 18(12):897-901. PubMed ID: 7527882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of residual aneuploid leukemic cells by "continuous gating".
    Kleine HD; Zech I; Nowak R; Oelschlägel U; Kundt G; Freund M
    Cytometry; 1999 May; 36(1):71-6. PubMed ID: 10331629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel and easy FxCycle™ violet based flow cytometric method for simultaneous assessment of DNA ploidy and six-color immunophenotyping.
    Tembhare P; Badrinath Y; Ghogale S; Patkar N; Dhole N; Dalavi P; Kunder N; Kumar A; Gujral S; Subramanian PG
    Cytometry A; 2016 Mar; 89(3):281-91. PubMed ID: 26671309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Minimal residual disease monitoring by flow cytometry in children with acute lymphoblastic leukemia].
    Popov AM; Verzhbitskaia TIu; Tsaur GA; Shorikov EV; Savel'ev LI; Tsvirenko SV; Fechina LG
    Klin Lab Diagn; 2010 Aug; (8):36-41. PubMed ID: 20886718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric DNA quantification in immunophenotyped cells as a sensitive method for determination of aneuploid multiple myeloma cells in peripheral blood stem cell harvests and bone marrow after therapy.
    Nowak R; Oelschlägel U; Range U; Bergmann S; Bornhäuser M; Hölig C; Schuler U; Krebs U; Günther H; Kroschinsky F; Ehninger G
    Bone Marrow Transplant; 1999 May; 23(9):895-900. PubMed ID: 10338044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
    Liu YR; Wang H; Chang Y; Cheng YF; Fu JY; Zhang LP; Liu GL; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):327-31. PubMed ID: 16185473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Flow cytometric detection of minimal residual disease in pre-cursor-B-acute lymphoblastic leukemia on the basis of phenotypic aberrancies on minor leukemic cell populations].
    Wu M; Sun XF; Xu ZM; Zhang XY; Li FR; Wang XG; Chen XL; Lin HQ; Wen HG; Sun X; Song TW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):557-62. PubMed ID: 16129033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of early marrow response in childhood aneuploid acute lymphoblastic leukemia: flow cytometric DNA analysis versus standard morphology.
    Finn LS; Hawkins DS; Rutledge JC; Patterson K
    Pediatr Dev Pathol; 2004; 7(1):39-47. PubMed ID: 15255034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: implications for residual disease detection.
    Weir EG; Cowan K; LeBeau P; Borowitz MJ
    Leukemia; 1999 Apr; 13(4):558-67. PubMed ID: 10214862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined use of reverse transcriptase polymerase chain reaction and flow cytometry to study minimal residual disease in Philadelphia positive acute lymphoblastic leukemia.
    Muñoz L; López O; Martino R; Brunet S; Bellido M; Rubiol E; Sierra J; Nomdedéu JF
    Haematologica; 2000 Jul; 85(7):704-10. PubMed ID: 10897122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunophenotyping of Acute Lymphoblastic Leukemia.
    DiGiuseppe JA; Cardinali JL
    Methods Mol Biol; 2019; 2032():297-310. PubMed ID: 31522425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of FCM-DNA measurement in detecting minimal residual disease in leukemia.
    Zhang RX; Yao EG
    Chin Med J (Engl); 1990 Oct; 103(10):826-30. PubMed ID: 2125256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some limitations in the detection of residual aneuploid cells with dna quantification on immunophenotyped cells by flow cytometry.
    Nowak R; Oelschlägel U; Heider T; Naumann R; Ehninger G
    Br J Haematol; 2000 Sep; 110(3):751-3. PubMed ID: 10997996
    [No Abstract]   [Full Text] [Related]  

  • 15. DNA index and %S-phase cells determined in acute lymphoblastic leukemia of children: a report from studies ALL V, ALL VI, and ALL VII (1979-1991) of the Dutch Childhood Leukemia Study Group and The Netherlands Workgroup on Cancer Genetics and Cytogenetics.
    Smets LA; Slater R; van Wering ER; van der Does-van den Berg A; Hart AA; Veerman AJ; Kamps WA
    Med Pediatr Oncol; 1995 Dec; 25(6):437-44. PubMed ID: 7565305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance for minimal residual disease detection by 4 color flow cytometry in adult and childhood B lineage acute lymphoblastic leukemia].
    Liu YR; Zhang LP; Chang Y; Cheng YF; Fu JY; Li LD; Wang H; Liu GL; Chen SS; Huang XJ; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):302-5. PubMed ID: 16875577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter study.
    Fossat C; Roussel M; Arnoux I; Asnafi V; Brouzes C; Garnache-Ottou F; Jacob MC; Kuhlein E; Macintyre-Davi E; Plesa A; Robillard N; Tkaczuk J; Ifrah N; Dombret H; Béné MC; Baruchel A; Garand R;
    Cytometry B Clin Cytom; 2015 Jan; 88(1):21-9. PubMed ID: 25363877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD34 immunoperoxidase staining in paraffin sections of acute leukemia: comparison with flow cytometric immunophenotyping.
    Hanson CA; Ross CW; Schnitzer B
    Hum Pathol; 1992 Jan; 23(1):26-32. PubMed ID: 1371985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.